|
JARID2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.384700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.676030E-02 |
| Normal-vs-Stage2 |
1.214040E-02 |
| Normal-vs-Stage3 |
1.124440E-03 |
| Normal-vs-Stage4 |
2.352900E-04 |
| Stage1-vs-Stage2 |
5.468400E-01 |
| Stage1-vs-Stage3 |
6.927900E-02 |
| Stage1-vs-Stage4 |
2.644000E-02 |
| Stage2-vs-Stage3 |
2.991000E-01 |
| Stage2-vs-Stage4 |
1.412010E-01 |
| Stage3-vs-Stage4 |
6.231600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.295400E-03 |
| Normal-vs-AfricanAmerican |
1.056420E-01 |
| Normal-vs-Asian |
5.383600E-02 |
| Caucasian-vs-AfricanAmerican |
7.777000E-01 |
| Caucasian-vs-Asian |
7.598000E-01 |
| AfricanAmerican-vs-Asian |
9.572600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.808280E-02 |
| Normal-vs-Female |
3.857800E-03 |
| Male-vs-Female |
5.764000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.694300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.841500E-03 |
| Normal-vs-Age(61-80Yrs) |
9.425900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.901240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.957400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.549700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.370000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.285000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.956800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.633600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.741600E-02 |
| Classical-VS-Follicular |
1.020050E-01 |
| Classical-VS-Other |
7.961800E-01 |
| Classical-VS-Normal |
2.370000E-02 |
| Tall-VS-Follicular |
3.389400E-01 |
| Tall-VS-Other |
4.800000E-01 |
| Tall-VS-Normal |
6.735300E-03 |
| Follicular-VS-Other |
6.454400E-01 |
| Follicular-VS-Normal |
6.613000E-04 |
| Other-VS-Normal |
9.172000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.314460E-02 |
| Normal-vs-N1 |
4.618400E-04 |
| N0-vs-N1 |
1.400840E-01 |
|
|
